For this, we developed 2 sandwich ELISA systems based on an anti–IL-33 coating antibody and a detection antibody specific for either dsDNA, the most prevalent nucleic acid in SLE ICs, or neutrophil myeloperoxidase (MPO). This evidence concerns the gene IL33 and systemic lupus erythematosus.